Huashan Hospital, formerly the Chinese Red Cross General Hospital, is a teaching hospital in Shanghai, China, affiliated with the Shanghai Medical College of Fudan University.

There are 1,216 (main branch) beds in Huashan Hospital Affiliated to Fudan University.

During the past decade, Huashan Hospital Affiliated to Fudan University conducted 125 clinical trials. In the 10-year time frame, 125 clinical trials started and 18 clinical trials were completed, i.e. on average, 14.4% percent of trials that started reached the finish line to date. In the past 5 years, 92 clinical trials started and 14 clinical trials were completed. i.e. 15.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Huashan Hospital Affiliated to Fudan University" #1 sponsor was "Huashan Hospital" with 23 trials, followed by "Hoffmann-La Roche" with 12 trials sponsored, "Eli Lilly and Company" with 9 trials sponsored, "Fudan University" with 8 trials sponsored and "TaiGen Biotechnology Co., Ltd." with 8 trials sponsored. Other sponsors include 80 different institutions and companies that sponsored additional 61 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Huashan Hospital Affiliated to Fudan University" #1 collaborator was "Huashan Hospital" with 6 trials as a collaborator, "Incyte Corporation" with 3 trials as a collaborator, "Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine" with 3 trials as a collaborator, "Shanghai Zhongshan Hospital" with 3 trials as a collaborator and "Changhai Hospital" with 2 trials as a collaborator. Other collaborators include 149 different institutions and companies that were collaborators in the rest 143 trials.

According to Clinical.Site data, the most researched conditions in "Huashan Hospital Affiliated to Fudan University" are "Healthy" (8 trials), "COVID-19" (7 trials), "Glioma" (4 trials), "Acute Ischemic Stroke" (3 trials) and "Alzheimer Disease" (3 trials). Many other conditions were trialed in "Huashan Hospital Affiliated to Fudan University" in a lesser frequency.

Most popular intervention types in "Huashan Hospital Affiliated to Fudan University" are "Drug" (109 trials), "Other" (15 trials), "Biological" (10 trials), "Device" (10 trials) and "Procedure" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (36 trials), "placebo" (5 trials), "Atezolizumab" (3 trials), "Baricitinib" (3 trials) and "Empagliflozin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Huashan Hospital Affiliated to Fudan University" are 131 trials for "All" genders, 11 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are 64 active trials in "Huashan Hospital Affiliated to Fudan University". 5 are not yet recruiting, 35 are recruiting, 23 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 51 completed trials in Huashan Hospital Affiliated to Fudan University, 1 suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Huashan Hospital Affiliated to Fudan University, 27 "Phase 1" clinical trials were conducted, 31 "Phase 2" clinical trials and 53 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 22 trials that are defined as “Not Applicable".